Kyowa Kirin Co., Ltd.

Mar 08, 2025

AMGEN AND KYOWA KIRIN PROVIDE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 IGNITE STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS

Feb 18, 2021

Kyowa Kirin Announces Positive Phase 2 Results for KHK4083 in Patients with Moderate to Severe Atopic Dermatitis

Feb 07, 2021

A Novel Drug-Device Combination Product Using Terumo's Automated Injection Device Completes Clinical Study in Japan

Oct 22, 2020

Ardelyx and Kyowa Kirin Highlight New Data Supporting the Clinical Safety and Efficacy of First-In-Class, Phosphate Absorption Inhibitor Tenapanor at ASN's Kidney Week 2020

May 14, 2020

MEI Pharma and Kyowa Kirin Announces ME-401 Phase 1b Study to be Highlighted in a Presentation at the Virtual Edition of the 25th European Hematology Association Annual Congress

Apr 14, 2020

MEI Pharma and Kyowa Kirin Announce Global License, Development and Commercialization Agreement for ME-401